Expression and Distribution of S-100, CD83, and Costimulatory Molecules (CD80 and CD86) in Tissues of Thyroid Papillary Carcinoma

REFERENCES

• Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Bugis S, Filipenko D, Huntsman D, Gilks B. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann Surg Oncol 2007;14:719–729.
   PubMed Web of Science ®Google Scholar
• Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer 2009;16:17–44.
   PubMed Web of Science ®Google Scholar
• Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003;19:225–234.
   PubMed Web of Science ®Google Scholar
• Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999;5:405–411.
   PubMed Web of Science ®Google Scholar
• Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, Lanier LL, Liu YJ. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 2001;193:1221–1226.
   PubMed Web of Science ®Google Scholar
• Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA, Lombard LA, Gray GS, Nadler LM. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909–911. doi: 10.1126.
   PubMed Web of Science ®Google Scholar
• Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233–258.
   PubMed Web of Science ®Google Scholar
• Tang KF, Chan SH, Loh KS, Chong SM, Wang D, Yeoh KH, Hu H. Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: indicative of an activated status. Cancer Lett 1999;140:93–98.
   PubMed Web of Science ®Google Scholar
• Yang WF, Yu JM, Zuo WS, Wang SZ. Expression of CD80, CD86, TGF-beta1 and IL-10 mRNA in the esophageal carcinoma. Zhonghua Zhong Liu Za Zhi (Chinese Journal of Oncology) 2006;28(10):762–765.
   PubMedGoogle Scholar
• Chen S, Luo YP, Zhang JK, Yang W, Zhen ZC, Chen LX, Zhang W. Study on immune function of dendritic cells in patients with esophageal carcinoma. World J Gastroenterol 2002;8:203–207.
   PubMedGoogle Scholar
• Tirapu I, Huarte E, Guiducci C, Arina A, Zaratieaui M, Murillo O, Gonzalez A, Berasain C, Berraondo P, Fortes P, Prieto J, Colombo MP, Chen L, Melero I. Low surface expression of B7–1 (CD80) is an immunoescape mechanism of colon carcinoma. Cancer Res 2006;66(4):2442–2450.
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Higashi T, Nouso K, Nakatsukasa H, Kobayashi Y, Uemura M, Nakamura S, Sato S, Hanafusa T, Yumoto Y, Naito I, Shiratori Y. Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma 2004;19(10):1121–1127.
   Google Scholar
• Kilicarslan B, Pesterelli EH, Oren N Sarqin FC, Karpuzoqlu G. Epithelial membrane antigen and S-100 protein expression in benign and malignant papillary thyroid neoplasms. Adv Clin Path 2000;4(4):155–158.
   PubMedGoogle Scholar
• Li YQ, Zeng BH. In vitro culture and anti-cancer immunity of dendritic cells. Chin J of Cancer Prev & Treat 2001;8(1):78–80.
   Google Scholar
• Chen S, Akbar SM, Tanimoto K, Ninomiya T, Iuchi H, Michitaka K, Horiike N, Onji M. Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis. Cancer Lett 2000;148(1):49–57.
   PubMedGoogle Scholar
• Xu WC, Chen SR, Huang JX, Zheng ZC, Chen LX, Lin JJ, Li YG. Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in the thyroid tissues of autoimmune thyroid diseases. Eur J Histochem 2007;51(4):291–300.
   PubMed Web of Science ®Google Scholar
• Strand S, Galle PR. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. Mol Med Today 1998;4:63–68.
   PubMedGoogle Scholar
• Vieweg J, Jackson A. Modulation of antitumor responses by dendritic cells. Springer Semin. Immunopathol 2005;26:329–341.
   PubMed Web of Science ®Google Scholar
• Rasaiyaah J, Yong K, Katz DR, Kellam P, and Chain BM. Dendritic cells and myeloid leukaemias: plasticity and commitment in cell differentiation. Br J Haematol 2007;138:281–290.
   PubMed Web of Science ®Google Scholar
• Demetris AJ, Sever C, Kakizoe S, Oguma S, Starzl TE, Jaffe R. S100 protein-positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases, relevance to pathogenesis. Am J Pathol 1998;134:741–747.
   Google Scholar
• Ishigami S, Aikou T, Natsugoe S, Hokita S, Iwashige H, Tokushige M, Sonoda S. Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 1998;55:65–69.
   Web of Science ®Google Scholar
• Pfragner R, Skofitsch G, Hoger H, Jech M, Rinner B, Siegl V, Niederle B, Gnant M, Friedl J, Stift A. Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination. Anticancer Res 2005;25(6B):4225–4230.
   PubMed Web of Science ®Google Scholar
• Schott M, Scherbaum WA. Immunotherapy and gene therapy of thyroid cancer. Minerva Endocrinol 2004;29(4):175–187.
   PubMedGoogle Scholar
• Woods GM, Doherty KV, Malley RC, Rist MJ, Muller HK. Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression. Immunology 2000;99:16–22.
   PubMed Web of Science ®Google Scholar
• Zhang JK, Sun JL, Chen HB, Zeng Y and Qu YJ. Influence of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor on anti-hepatoma activities of human dendritic cells. World J Gastroenterol 2000;6:718–720.
   PubMed Web of Science ®Google Scholar
• Zhang JK, Li J, Chen HB, Sun JL, Qu YJ, Lu JJ. Antitumor activities of human dendritic cells derived from peripheral and cord blood. World J Gastroenterol 2002;8:87–90.
   PubMed Web of Science ®Google Scholar
• Yamakawa M, Kato H, Takagi S, Karube Y, Seki K, Imai Y. Dendritic cells in various human thyroid diseases. In Vivo 1993;7(3):249–256.
   PubMedGoogle Scholar
• Stulk J, Osterreicher J, Koupilova K, Knizek J, Macela A, bures J, Jandík P, Langr F, Dedic K, Jungblut PR. The analysis of S100 A9 and S100 A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S-100 A9 and S-100 A8 positive cells underlie and invade tumor mass. Electrophoresis 1999;20(4–5):1047–1054.
   PubMed Web of Science ®Google Scholar
• Yinemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, Kinoshita K, Ninomiya I, Sugiyama K, Heizmann CW, Schafer BW, Sasaki T. Inverse expression of S100 A4 and Ecadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 2000;6(11):4234–4242.
   PubMed Web of Science ®Google Scholar
• Rudland PS, Platt Higgins A, Renshaw C, West CR, Winstanley JHR, Robertson L, Barraclough R. Prognostic significance of the metastasis-inducing protein S100 A4(p9Ka) in human breast cancer. Cancer Res 2000;60(6):1595–1603.
   PubMed Web of Science ®Google Scholar
• Rustandi RR, Baldisseri DM, Weber DJ. Structure of the negative regulatory domain of p53 bound to S100B (betabeta). Nat Struct Biol 2000;7(7):570–574.
   PubMedGoogle Scholar
• Xu W, Chen S, Huang J, Zhang Z, Chen L, Zhang W. The expression and distribution of S-100 protein and CD 83 in thyroid tissues of autoimmune thyroid diseases. Cell Mol Immunol 2004;1(5):378–382.
   PubMed Web of Science ®Google Scholar
• Pesce G, Fiorino N, Riccio AM, Montagna P, Torre G, Salmaso C, Altrinetti V, Bagnasco M. Different intrathyroid expression of intercellular adhesion molecule-1 (ICAM-1) in Hashimoto's thyroiditis and Graves’ disease: analysis at mRNA level and association with B7. 1 costimulatory molecule. J Endocrinol Invest 2002;25(3):289–295.
   PubMed Web of Science ®Google Scholar
• Chen SR, Lou YP, Zhang JK, Yang W, Zhen ZC, Chen LX, Zhang W. The study on immune function of dendritic cells in patients with esophageal carcinoma. World J Gastroenterol 2004;10(7):934–939.
   PubMed Web of Science ®Google Scholar
• Mogi S, Sakurai J, Kohsaka T, Enomoto S, Yagita H, Okumura K, Azuma M. Tumour rejection by gene transfer of 4–1BB ligand into a CD80+ murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumor and host cells. Immunology 2000;101:541–547.
   PubMed Web of Science ®Google Scholar
• Zai SH, Liu JB, Zhu P and Wang YH. The expression of CD80 and CD86 in hepatocarcinoma and cirrhosis tissues. J Fourth Mil Med Univ 2001;21:26–27.
   Google Scholar
• Ito T, Amakawa R, Inaba M, Ikehara S, Inaba K, Fukuhara S. Differential regulation of human bood dendritic cell subsets by IFNs. Immunology 2001;104:2961–2969.
   Google Scholar
• Xing LH, Wang FS, Liu MX, Zhu CL. Dendritic cells and liver diseases. Shijie Huaren Xiaohua Zazhi 2000;8:1276–1279.
   Google Scholar
• Avigan D. Dendritic cells: development, function and potential use for cancer immunotherapy. Blood Rev 1999;13:51–64.
   PubMed Web of Science ®Google Scholar
• Li X, Takahashi Y, Sakamoto K, Nakashima T. Expression of dendritic cell phenotypic antigens in cervical lymph nodes of patients with hypopharyngeal and laryngeal carcinoma. J Laryngol Otol Suppl 2009;31:5–10.
   PubMedGoogle Scholar
• Kara PP, Ayhan A, Caner B, Gultekin M, Ugur O, Bozkurt MF, Usubutun A, Uner A. Analysis of dendritic cells in sentinel lymph nodes of patients with endometrial and patients with cervical cancers. Int J Gynecol Cancer 2009;19(7):1239–1243.
   PubMed Web of Science ®Google Scholar
• Fiumara A, Belfiore A, Russo G, Salomone E, Santonocito GM, Ippolito O, Vigneri R, Gangemi P. In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab 1997;82:1615–1620.
   PubMed Web of Science ®Google Scholar
• Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T, Nakayama I. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 1998;8:197–202.
   PubMed Web of Science ®Google Scholar
• Yan XM, Guo J, Pichurin P, Tanaka K, Jaume JC, Rapoport B, McLachlan SM Cytokines, IgG subclasses and costimulation in a mouse model of thyroid autoimmunity induced by injection of fibroblasts co-expressing MHC class II and thyroid autoantigens. Clin Exp Immunol 2000;122:170–179.
   PubMed Web of Science ®Google Scholar
• Maile R, Elsegood KA, Harding TC, Uney JB, Stewart CE, Banting G, Dayan CM. Effective formation of major histocompatibility complex class II-peptide complexes from endogenous antigen by thyroid epithelial cells. Immunology 2000;99:367– 374.
   PubMed Web of Science ®Google Scholar
• Thomas GR, Wen J. Endogenous expression of CD80 co-stimulatory molecules facilitates in vivo tumor regression of oral squamous carcinoma. Anticancer Res 2006;26:4093–4101.
   PubMed Web of Science ®Google Scholar
• Yang G, Hellstrom KE, Hellstrom I, Chen L. Antitumor immunity elicited by tumor cells transfected with B7–2, a second ligand for CD28/CTLA-4 costimulatory molecules. J Immunol 1995;154:2794–2800.
   PubMed Web of Science ®Google Scholar
• Chen L, Ashe S, Brady WA, Hellström I, Hellström KE, Ledbetter JA, McGowan P, Linsley PS. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992;71:1093–1102.
   PubMed Web of Science ®Google Scholar